Home » Stocks » AOLS

Aeolus Pharmaceuticals Inc. (AOLS)

Stock Price: $0.0070 USD 0.0009 (14.75%)
Updated Apr 14, 2021 10:18 AM EDT - Market closed
Market Cap 167,293
Revenue (ttm) 771,000
Net Income (ttm) -4.09M
Shares Out 152.09M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 14
Last Price $0.0070
Previous Close $0.0061
Change ($) 0.0009
Change (%) 14.75%
Day's Open 0.0060
Day's Range 0.0060 - 0.0070
Day's Volume 127,572
52-Week Range 0.0010 - 0.0200

News

There are no news available yet.

About AOLS

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which ... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Feb 1, 1996
CEO
John McManus
Employees
4
Stock Exchange
OTCMKTS
Ticker Symbol
AOLS
Full Company Profile

Financial Performance

In 2016, AOLS's revenue was $2.08 million, a decrease of -33.27% compared to the previous year's $3.11 million. Losses were -$3.56 million, 35.4% more than in 2015.

Financial Statements